Cargando…

miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation

In hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co‐infected patients, HIV enhances HCV replication and liver damage. Several microRNAs (miRNAs), active in pro‐fibrotic and inflammatory pathways, have been implicated in the pathogenesis of this phenomenon. However, these miRNAs have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bulfoni, Michela, Pravisani, Riccardo, Dalla, Emiliano, Cesselli, Daniela, Hidaka, Masaaki, Di Loreto, Carla, Eguchi, Susumu, Baccarani, Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360178/ https://www.ncbi.nlm.nih.gov/pubmed/33818800 http://dx.doi.org/10.1002/jmv.26999

Ejemplares similares

Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile
por: Dalla, Emiliano, et al.
Publicado: (2022)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Re-thinking of T-tube use in whole liver transplantation: an analysis on the risk of delayed graft function
por: Pravisani, Riccardo, et al.
Publicado: (2022)

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
por: Poordad, Fred, et al.
Publicado: (2017)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Association between the donor to recipient ICG-PDR variation rate and the functional recovery of the graft after orthotopic liver transplantation: A case series
por: Cherchi, Vittorio, et al.
Publicado: (2021)

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
por: Gambato, Martina, et al.
Publicado: (2023)

HCV and Oxidative Stress in the Liver
por: Ivanov, Alexander V., et al.
Publicado: (2013)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Management of HCV Infection and Liver Transplantation
por: Schiano, Thomas D., et al.
Publicado: (2006)

The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle
por: Kunden, Rasika D., et al.
Publicado: (2020)

β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development
por: Ling, Yue-Ming, et al.
Publicado: (2017)

Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy
por: Klein, Fritz, et al.
Publicado: (2016)

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients
por: Ferri, Flaminia, et al.
Publicado: (2019)

Epidemiology and Elimination of HCV-Related Liver Disease
por: Pradat, Pierre, et al.
Publicado: (2018)

Dilemma of HCV Infection in Renal Transplant Recipients
por: Ashry Ahmed Gheith, Osama
Publicado: (2011)

A Donor Age-Based and Graft Volume–Based Analysis for Living Donor Liver Transplantation in Elderly Recipients
por: Imamura, Hajime, et al.
Publicado: (2017)

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
por: Harris, R. J., et al.
Publicado: (2016)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation
por: Wieczorek-Godlewska, Renata, et al.
Publicado: (2017)

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors
por: Latronico, Tiziana, et al.
Publicado: (2016)

Successful Treatment of a Reinfected Liver Graft Because of Receipt of a HCV-Positive Kidney
por: Azhari, Hassan, et al.
Publicado: (2020)

Heterogeneous distribution of HCV genotypes and growing menace of mixed HCV infection in blood recipients in Khyber Pakhtunkhwa
por: Attaullah, Sobia, et al.
Publicado: (2017)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer
por: Petkevich, Alisa A., et al.
Publicado: (2021)

Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
por: Stasi, Cristina, et al.
Publicado: (2014)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

Deep Sequencing Analysis of HCV NS3 Resistance-Associated Variants and Mutation Linkage in Liver Transplant Recipients
por: Kirst, Mariana E., et al.
Publicado: (2013)

“Raising HOPE”: Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era
por: Cotter, Thomas G., et al.
Publicado: (2021)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis
por: El-Ahwany, Eman, et al.
Publicado: (2016)

Mitochondrial apurinic/apyrimidinic endonuclease 1 enhances mtDNA repair contributing to cell proliferation and mitochondrial integrity in early stages of hepatocellular carcinoma
por: Bazzani, Veronica, et al.
Publicado: (2020)

Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV Infection
por: El-Shabrawi, Mortada Hassan, et al.
Publicado: (2011)

New Insights in Recurrent HCV Infection after Liver Transplantation
por: Hsu, Shih-Hsien, et al.
Publicado: (2013)

Lymphocytes as Liver Damage Mirror of HCV Related Adipogenesis Deregulation
por: Minutolo, Antonella, et al.
Publicado: (2014)

Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis
por: Karidis, Nikolaos P., et al.
Publicado: (2015)

Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection
por: Barone, Michele, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2lhidb0sk2biroj69v7tn8q477